Related Experiment Video
Updated: May 29, 2025

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
Published on: October 16, 2010
Breast Cancer Risk and Management in the Endocrine Clinic: A Comprehensive Review.
1Centre for Endocrinology, Queen Mary University, London, UK.
Women with endocrine disorders face elevated breast cancer risk, particularly those with diabetes, obesity, or specific genetic conditions like MEN1. Personalized screening and management, including cautious Menopausal Hormone Therapy (MHT) use, are crucial for early detection and improved outcomes.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Women with endocrine disorders often have unique breast cancer risk profiles.
- Metabolic factors like diabetes and obesity, and Menopausal Hormone Therapy (MHT) significantly influence this risk.
Purpose of the Study:
- To analyze breast cancer risk, diagnostic methods, and management strategies for women with endocrine disorders.
- To emphasize the impact of metabolic factors and MHT on breast cancer in this population.
Main Methods:
- Comprehensive review of endocrine disorders including MEN1, MEN2, VHL, PPGL, Acromegaly, Hyperprolactinaemia, PCOS, CAH, Turner Syndrome, diabetes, obesity, and MHT.
- Critical appraisal of associations with breast cancer risk, screening, and treatment.
Main Results:
- Elevated breast cancer risk noted in MEN1 (MRI screening by age 40 recommended), with emerging treatments for MEN2.
- Diabetes and obesity are major modifiable risk factors, increasing incidence and worsening outcomes, especially for triple-negative breast cancer (TNBC).
- Combined estrogen-progestogen MHT increases risk, while estrogen-only MHT may reduce it post-hysterectomy; individualized risk assessment is vital.
Conclusions:
- Personalized breast cancer screening and management are essential for women with endocrine and metabolic disorders.
- Early MRI screening for MEN1 and interventions for diabetes/obesity are critical.
- Individualized risk stratification for MHT is necessary, with further research needed for robust guidelines.
Related Concept Videos
What is the Endocrine System?
Cancer Survival Analysis
Disorders of the Female Reproductive System
Cancer Prevention
Some...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Pancreatitis II: Collaborative Care
Assessment:

